MANUFACTURING LICENSE AND TECHNOLOGY TRANSFER AGREEMENTConfidential Materials Omitted and Filed Separately With the Securities and Exchange Commission • September 11th, 2018 • Applied Genetic Technologies Corp • Biological products, (no disgnostic substances) • Delaware
This Manufacturing License and Technology Transfer Agreement (“Agreement”) is entered into as of July 1, 2015 (the “Execution Date”), and effective as of the Effective Date, by and between Applied Genetic Technologies Corporation, having a place of business at 11801 Research Drive, Suite D, Alachua, FL 32615 (“AGTC”) and Biogen MA Inc. (“LICENSEE”), having a place of business at 250 Binney Street, Cambridge, MA 02142. AGTC and LICENSEE are referred to collectively hereinafter as the “Parties” and individually as a “Party”.
COLLABORATION AND LICENSE AGREEMENT by and between BIOGEN MA INC. and APPLIED GENETIC TECHNOLOGIES CORPORATION July 1, 2015Confidential Materials Omitted and Filed Separately With the Securities and Exchange Commission • September 10th, 2015 • Applied Genetic Technologies Corp • Biological products, (no disgnostic substances) • Delaware
This Collaboration and License Agreement (the “Agreement”) is entered into as of July 1, 2015 (the “Execution Date”), by and between Biogen MA Inc., a corporation organized and existing under the laws of the Commonwealth of Massachusetts and having a principal place of business at 250 Binney Street, Cambridge, MA 02142 (“Biogen”) and Applied Genetic Technologies Corporation, a corporation organized and existing under the laws of Delaware and having a principal place of business at 11801 Research Drive, Suite D, Alachua, FL 32615 (“AGTC”). Biogen and AGTC may each be referred to herein individually as a “Party” and collectively as the “Parties.”
